Dendritic cell MST1 inhibits Th17 differentiation

Nature Communications

Volumn 8, Issue , 2017, Pages

  Li, Chunxiao ^a,b   Bi, Yujing ^c   Li, Yan ^a,b   Yang, Hui ^b   Yu, Qing ^a   Wang, Jian ^a,b   Wang, Yu ^a,b   Su, Huilin ^a,b   Jia, Anna ^a   Hu, Ying ^a   Han, Linian ^a   Zhang, Jiangyuan ^a   Li, Simin ^a   Tao, Wufan ^b   Liu, Guangwei ^a,b  

^a Beijing Normal University   (China)

^b FUDAN UNIVERSITY   (China)

^c BEIJING INSTITUTE OF MICROBIOLOGY AND EPIDEMIOLOGY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA INTERFERON; CD40 ANTIGEN; CD86 ANTIGEN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 17; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 23; INTERLEUKIN 4; INTERLEUKIN 6; MAMMALIAN STERILE 20 LIKE KINASE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE P38; PROTEIN KINASE; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE; STK4 PROTEIN, MOUSE;

ANTIGEN; ANTIMICROBIAL ACTIVITY; CELLS AND CELL COMPONENTS; ENZYME ACTIVITY; FUNGUS; GENE EXPRESSION; IMMUNITY; INHIBITION; MAMMAL; SECRETION;

ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; CELL ACTIVITY; CELL DIFFERENTIATION; CHIMERA; COCULTURE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; ENZYME ACTIVATION; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; HOMEOSTASIS; IMMUNITY; IMMUNIZATION; IMMUNOCOMPETENT CELL; IN VITRO STUDY; LAMINA PROPRIA; LYMPH NODE; LYMPHOCYTE; MACROPHAGE; MOUSE; NEUTROPHIL; NONHUMAN; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH17 CELL; TH2 CELL; ANIMAL; C57BL MOUSE; CELL CULTURE; GENETICS; IMMUNOLOGY; KNOCKOUT MOUSE; METABOLISM; TRANSGENIC MOUSE;

MAMMALIA;

ANIMALS; CELL DIFFERENTIATION; CELLS, CULTURED; DENDRITIC CELLS; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; INTERLEUKIN-17; INTERLEUKIN-6; MICE, INBRED C57BL; MICE, KNOCKOUT; MICE, TRANSGENIC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PROTEIN-SERINE-THREONINE KINASES; SIGNAL TRANSDUCTION; TH17 CELLS;

EID: 85011599296     PISSN: None     EISSN: 20411723     Source Type: Journal    
DOI: 10.1038/ncomms14275     Document Type: Article

References (70)

1. Zhu, J., Yamane, H. & Paul, W. E. Differentiation of effector CD4 T cell populations. Annu. Rev. Immunol. 28, 445-489 (2010).
2. Yosef, N. et al. Dynamic regulatory network controlling TH17 cell differentiation. Nature 496, 461-468 (2013).
3. Ansel, K. M., Lee, D. U. & Rao, A. An epigenetic view of helper T cell differentiation. Nat. Immunol. 4, 616-623 (2003).
4. Zhou, L., Chong, M. M. & Littman, D. R. Plasticity of CD4+ T cell lineage differentiation. Immunity 30, 646-655 (2009).
5. Murphy, K. M. & Reiner, S. L. The lineage decisions of helper T cells. Nat. Rev. Immunol. 2, 933-944 (2002).
6. Wang, Y. et al. Histone deacetylase SIRT1 negatively regulates the differentiation of interleukin-9-producing CD4(+) T cells. Immunity 44, 1337-1349 (2016).
7. Torchinsky, M. B., Garaude, J., Martin, A. P. & Blander, J. M. Innate immune recognition of infected apoptotic cells directs T(H)17 cell differentiation. Nature 458, 78-82 (2009).
8. Chung, Y. et al. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 (2009).
9. Segura, E. et al. Human inflammatory dendritic cells induce Th17 cell differentiation. Immunity 38, 336-348 (2013).
10. Jones, G. W. et al. Loss of CD4+ T cell IL-6R expression during inflammation underlines a role for IL-6 trans signaling in the local maintenance of Th17 cells. J. Immunol. 184, 2130-2139 (2010).
11. Dileepan, T. et al. Robust antigen specific th17 T cell response to group A Streptococcus is dependent on IL-6 and intranasal route of infection. PLoS Pathog. 7, e1002252 (2011).
12. Wilson, J. M. et al. The A2B adenosine receptor promotes Th17 differentiation via stimulation of dendritic cell IL-6. J. Immunol. 186, 6746-6752 (2011).
13. Sonderegger, I. et al. GM-CSF mediates autoimmunity by enhancing IL-6-dependent Th17 cell development and survival. J. Exp. Med. 205, 2281-2294 (2008).
14. Kishimoto, T. Interleukin-6: from basic science to medicine-40 years in immunology. Annu. Rev. Immunol. 23, 1-21 (2005).
15. Zhou, L. et al. IL-6 programs T(H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat. Immunol. 8, 967-974 (2007).
16. Liu, G. et al. The receptor S1P1 overrides regulatory T cell-mediated immune suppression through Akt-mTOR. Nat. Immunol. 10, 769-777 (2009).
17. Liu, G., Yang, K., Burns, S., Shrestha, S. & Chi, H. The S1P(1)-mTOR axis directs the reciprocal differentiation of T(H)1 and T(reg) cells. Nat. Immunol. 11, 1047-1056 (2010).
18. Liu, G. et al. Dendritic cell SIRT1-HIF1alpha axis programs the differentiation of CD4+ T cells through IL-12 and TGF-beta1. Proc. Natl Acad. Sci. USA 112, E957-E965 (2015).
19. Huang, G., Wang, Y., Shi, L. Z., Kanneganti, T. D. & Chi, H. Signaling by the phosphatase MKP-1 in dendritic cells imprints distinct effector and regulatory T cell fates. Immunity 35, 45-58 (2011).
20. Huang, G. et al. Signaling via the kinase p38alpha programs dendritic cells to drive TH17 differentiation and autoimmune inflammation. Nat. Immunol. 13, 152-161 (2012).
21. Manicassamy, S. et al. Activation of beta-catenin in dendritic cells regulates immunity versus tolerance in the intestine. Science 329, 849-853 (2010).
22. Meng, Z. et al. MAP4K family kinases act in parallel to MST1/2 to activate LATS1/2 in the Hippo pathway. Nat. Commun. 6, 8357 (2015).
23. Graves, J. D. et al. Caspase-mediated activation and induction of apoptosis by the mammalian Ste20-like kinase Mst1. EMBO J. 17, 2224-2234 (1998).
24. Yamamoto, S. et al. Activation of Mst1 causes dilated cardiomyopathy by stimulating apoptosis without compensatory ventricular myocyte hypertrophy. J. Clin. Invest. 111, 1463-1474 (2003).
25. Cinar, B. et al. The pro-Apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1. EMBO J. 26, 4523-4534 (2007).
26. Zhou, D. et al. The Nore1B/Mst1 complex restrains antigen receptor-induced proliferation of naive T cells. Proc. Natl Acad. Sci. USA 105, 20321-20326 (2008).
27. Song, H. et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression. Proc. Natl Acad. Sci. USA 107, 1431-1436 (2010).
28. Ardestani, A. et al. MST1 is a key regulator of beta cell apoptosis and dysfunction in diabetes. Nat. Med. 20, 385-397 (2014).
29. Yuan, F. et al. MST1 promotes apoptosis through regulating Sirt1-dependent p53 deacetylation. J. Biol. Chem. 286, 6940-6945 (2011).
30. Katagiri, K. et al. Mst1 controls lymphocyte trafficking and interstitial motility within lymph nodes. EMBO J. 28, 1319-1331 (2009).
31. Katagiri, K., Imamura, M. & Kinashi, T. Spatiotemporal regulation of the kinase Mst1 by binding protein RAPL is critical for lymphocyte polarity and adhesion. Nat. Immunol. 7, 919-928 (2006).
32. Dong, Y. et al. A cell-intrinsic role for Mst1 in regulating thymocyte egress. J. Immunol. 183, 3865-3872 (2009).
33. Ueda, Y. et al. Mst1 regulates integrin-dependent thymocyte trafficking and antigen recognition in the thymus. Nat. Commun. 3, 1098 (2012).
34. Mou, F. et al. TheMst1 and Mst2 kinases control activation of rho family GTPases and thymic egress of mature thymocytes. J. Exp. Med. 209, 741-759 (2012).
35. Du, X. et al. Mst1/Mst2 regulate development and function of regulatory T cells through modulation of Foxo1/Foxo3 stability in autoimmune disease. J. Immunol. 192, 1525-1535 (2014).
36. Praskova, M., Xia, F. & Avruch, J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation. Curr. Biol. 18, 311-321 (2008).
37. Geng, J. et al. Kinases Mst1 and Mst2 positively regulate phagocytic induction of reactive oxygen species and bactericidal activity. Nat. Immunol. 16, 1142-1152 (2015).
38. Rothhammer, V. et al. Th17 lymphocytes traffic to the central nervous system independently of alpha4 integrin expression during EAE. J. Exp. Med. 208, 2465-2476 (2011).
39. Bailey, S. L., Schreiner, B., McMahon, E. J. & Miller, S. D. CNS myeloid DCs presenting endogenous myelin peptides preferentially polarize CD4+ T(H)-17 cells in relapsing EAE. Nat. Immunol. 8, 172-180 (2007).
40. Karulin, A. Y., Quast, S., Hesse, M. D. & Lehmann, P. V. Neuroantigen-specific CD4 cells expressing interferon-gamma (IFN-gamma), interleukin (IL)-2 and IL-3 in a mutually exclusive manner prevail in experimental allergic encephalomyelitis (EAE). Cells 1, 576-596 (2012).
41. Isaksson, M., Lundgren, B. A., Ahlgren, K. M., Kampe, O. & Lobell, A. Conditional DC depletion does not affect priming of encephalitogenic Th cells in EAE. Eur. J. Immunol. 42, 2555-2563 (2012).
42. Huang, G., Shi, L. Z. & Chi, H. Regulation of JNK and p38 MAPK in the immune system: signal integration, propagation and termination. Cytokine 48, 161-169 (2009).
43. Ammit, A. J. et al. Sphingosine 1-phosphate modulates human airway smooth muscle cell functions that promote inflammation and airway remodeling in asthma. FASEB J. 15, 1212-1214 (2001).
44. Zhang, Y. et al. ZIP4 regulates pancreatic cancer cell growth by activating IL-6/STAT3 pathway through zinc finger transcription factor CREB. Clin. Cancer Res. 16, 1423-1430 (2010).
45. Graves, J. D., Draves, K. E., Gotoh, Y., Krebs, E. G. & Clark, E. A. Both phosphorylation and caspase-mediated cleavage contribute to regulation of the Ste20-like protein kinase Mst1 during CD95/Fas-induced apoptosis. J. Biol. Chem. 276, 14909-14915 (2001).
46. Creasy, C. L., Ambrose, D. M. & Chernoff, J. The Ste20-like protein kinase, Mst1, dimerizes and contains an inhibitory domain. J. Biol. Chem. 271, 21049-21053 (1996).
47. Schinkmann, K. & Blenis, J. Cloning and characterization of a human STE20-like protein kinase with unusual cofactor requirements. J. Biol. Chem. 272, 28695-28703 (1997).
48. Creasy, C. L. & Chernoff, J. Cloning and characterization of a human protein kinase with homology to Ste20. J. Biol. Chem. 270, 21695-21700 (1995).
49. Rawat, S. J. & Chernoff, J. Regulation of mammalian Ste20 (Mst) kinases. Trends Biochem. Sci. 40, 149-156 (2015).
50. Avruch, J. et al. Protein kinases of the Hippo pathway: regulation and substrates. Semin. Cell Dev. Biol. 23, 770-784 (2012).
51. Zhou, D. et al. Mst1 and Mst2 maintain hepatocyte quiescence and suppress hepatocellular carcinoma development through inactivation of the Yap1 oncogene. Cancer Cell 16, 425-438 (2009).
52. ONeill, E., Rushworth, L., Baccarini, M. & Kolch, W. Role of the kinase MST2 in suppression of apoptosis by the proto-oncogene product Raf-1. Science 306, 2267-2270 (2004).
53. Del Re, D. P. et al. Mst1 promotes cardiac myocyte apoptosis through phosphorylation and inhibition of Bcl-xL. Mol. Cell 54, 639-650 (2014).
54. Maejima, Y. et al. Mst1 inhibits autophagy by promoting the interaction between Beclin1 and Bcl-2. Nat. Med. 19, 1478-1488 (2013).
55. Pan, D. The hippo signaling pathway in development and cancer. Dev. Cell 19, 491-505 (2010).
56. Harvey, K. F., Zhang, X. & Thomas, D. M. The Hippo pathway and human cancer. Nat. Rev. Cancer 13, 246-257 (2013).
57. Yu, F. X. & Guan, K. L. The Hippo pathway: regulators and regulations. Genes Dev. 27, 355-371 (2013).
58. Johnson, R. & Halder, G. The two faces of Hippo: Targeting the Hippo pathway for regenerative medicine and cancer treatment. Nat. Rev. Drug Discov. 13, 63-79 (2014).
59. Zeng, Q. & Hong, W. The emerging role of the hippo pathway in cell contact inhibition, organ size control, and cancer development in mammals. Cancer Cell 13, 188-192 (2008).
60. Abdollahpour, H. et al. The phenotype of human STK4 deficiency. Blood 119, 3450-3457 (2012).
61. Nehme, N. T. et al. MST1 mutations in autosomal recessive primary immunodeficiency characterized by defective naive T-cell survival. Blood 119, 3458-3468 (2012).
62. Korn, T., Bettelli, E., Oukka, M. & Kuchroo, V. K. IL-17 and Th17 cells. Annu. Rev. Immunol. 27, 485-517 (2009).
63. Iwasaki, A. & Medzhitov, R. Regulation of adaptive immunity by the innate immune system. Science 327, 291-295 (2010).
64. LeibundGut-Landmann, S. et al. Syk-And CARD9-dependent coupling of innate immunity to the induction of T helper cells that produce interleukin 17. Nat. Immunol. 8, 630-638 (2007).
65. Jirmanova, L., Giardino Torchia, M. L., Sarma, N. D., Mittelstadt, P. R. & Ashwell, J. D. Lack of the T cell-specific alternative p38 activation pathway reduces autoimmunity and inflammation. Blood 118, 3280-3289 (2011).
66. Noubade, R. et al. Activation of p38 MAPK in CD4 T cells controls IL-17 production and autoimmune encephalomyelitis. Blood 118, 3290-3300 (2011).
67. Commodaro, A. G. et al. p38a MAP kinase controls IL-17 synthesis in Vogt-Koyanagi-Harada syndrome and experimental autoimmune uveitis. Invest. Ophthalmol. Vis. Sci. 51, 3567-3574 (2010).
68. Liu, G. et al. Kinase AKT1 negatively controls neutrophil recruitment and function in mice. J. Immunol. 191, 2680-2690 (2013).
69. Liu, G. et al. Targeting S1P1 receptor protects against murine immunological hepatic injury through myeloid-derived suppressor cells. J. Immunol. 192, 3068-3079 (2014).
70. Liu, G. et al. Phosphatase Wip1 negatively regulates neutrophil development through p38 MAPK-STAT1. Blood 121, 519-529 (2013).